Literature DB >> 9633884

Interferon alpha activates the tyrosine kinase Lyn in haemopoietic cells.

S Uddin1, I M Grumbach, T Yi, O R Colamonici, L C Platanias.   

Abstract

We investigated whether the src-family tyrosine kinase Lyn is involved in the generation of interferon alpha (IFN alpha) signals in haemopoietic cells. In vitro kinase assays using IFN alpha-sensitive cells of B-cell origin demonstrated the presence of IFN alpha-dependent kinase activity in anti-Lyn immunoprecipitates. Further studies demonstrated that Lyn associates via its src homology 2 (SH2) domain with the Janus family tyrosine kinase Tyk-2. This interaction was IFN alpha-dependent and involved direct binding of the SH2 domain of Lyn to the IFN alpha-activated form of Tyk-2. Thus, during binding of IFN alpha to its receptor in malignant haemopoietic cells, Lyn is engaged in an IFN alpha-signalling pathway, probably downstream of Tyk-2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9633884     DOI: 10.1046/j.1365-2141.1998.00731.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen.

Authors:  Natalie Sutkowski; Gang Chen; German Calderon; Brigitte T Huber
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 2.  IFNs-signaling effects on lung cancer: an up-to-date pathways-specific review.

Authors:  Vasiliki Galani; Michalis Kastamoulas; Anna Varouktsi; Evangeli Lampri; Antigoni Mitselou; Dimitrios L Arvanitis
Journal:  Clin Exp Med       Date:  2016-07-14       Impact factor: 3.984

3.  Parsing the Interferon Transcriptional Network and Its Disease Associations.

Authors:  Sara Mostafavi; Hideyuki Yoshida; Devapregasan Moodley; Hugo LeBoité; Katherine Rothamel; Towfique Raj; Chun Jimmie Ye; Nicolas Chevrier; Shen-Ying Zhang; Ting Feng; Mark Lee; Jean-Laurent Casanova; James D Clark; Martin Hegen; Jean-Baptiste Telliez; Nir Hacohen; Philip L De Jager; Aviv Regev; Diane Mathis; Christophe Benoist
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

4.  Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders.

Authors:  Annacarmen Petrizzo; Maria Lina Tornesello; Maria Napolitano; Giovanna D'Alessio; Angelo Salomone Megna; Riccardo Dolcetti; Valli De Re; Ena Wang; Franco M Marincola; Franco M Buonaguro; Luigi Buonaguro
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 5.  TYK2: An Upstream Kinase of STATs in Cancer.

Authors:  Katharina Wöss; Natalija Simonović; Birgit Strobl; Sabine Macho-Maschler; Mathias Müller
Journal:  Cancers (Basel)       Date:  2019-11-05       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.